RecruitingNCT05080712
Progression of Atrial Fibrillation in the Young
Sponsor
Karolinska Institutet
Enrollment
100 participants
Start Date
Sep 25, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to investigate the presence and magnitude of structural changes of the heart and their long-term development in young patients with atrial Fibrillation (AF), studied by echocardiographic measurements and plasma biomarkers and their association to AF burden, studied using long-term ECG
Eligibility
Min Age: 18 YearsMax Age: 50 Years
Inclusion Criteria2
- Atrial fibrillation
- Diagnosis of atrial fibrillation within one year of inclusion
Exclusion Criteria2
- Duration of atrial fibrillation over one year.
- Acute stressor for atrial fibrillation such as: acute ischemic heart disease or infection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05080712
Related Trials
The CONFORM Pivotal Trial
NCT0514779283 locations
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT072275327 locations
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT0645509846 locations
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698127 locations